Cowen & Co. Baral


Cowen Lifts Amicus Therapeutics, Inc. Price Target Following Scioderm Acquisition

In a research report released today, Cowen’s healthcare analyst Ritu Baral reiterated an Outperform rating on shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD), and raised the price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts